Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Co-Founder and CEO, DNAnexus
Director, Life Sciences Institute, University of Michigan
Co-Founder and CEO, Wetpaint
While San Diego has become a center of excellence for drug development, the prolonged development costs are pushing some entrepreneurs to explore the virtual business model as an alternative strategy for building a biotech startup. San Diego also is benefitting from increasing numbers of biotech and service companies that are now collaborating in San Diego. Biocom has organized this workshop to discuss how Trius Therapeutics and other companies developed their virtual business models. More information and online registration is available here.